The cardiometabolic care benefit that pays off for budgets and people
Embla combines GLP-1s with behavior-first care to drive meaningful, sustainable weight loss with just a fraction of the medication.
The more you use the app, the better results
What members achieve, and keep
With Embla, weight comes off and stay off. Members reach meaningful milestones, taper off GLP-1s, and maintain their results with long-term coaching.
Meaningful weight loss
23%lost ≥20%
51%lost ≥15%
51%lost ≥15%
Medication taper success
Structured taper from month 16, over 12 weeks
Only 28.8% escalated above 1 mg/week
Guided taper plans from coaches and clinicians
Sustainable outcomes
Weight stays off after taper
Habits hold with ongoing coaching
Results consistent across age, BMI, dose
A better GLP-1 benefit, with lower cost and higher impact
Embla helps employers offer the GLP-1 solution everyone’s asking about without the high price tag or complexity.
Embla’s model is designed to taper. Members use 55% less medication on average with no trade-off in outcomes.
Employees feel supported, empowered, and healthier, physically and mentally. That’s good for engagement, and even better for retention.
Offering Embla shows you’re invested in long-term health, not short-term trends. It’s a modern benefit that helps attract and keep great people.
Ready to rethink your
GLP-1 strategy?
Talk to our team to see how Embla works in practice and explore what cost reduction and clinical impact could look like for your organization.